D-Index & Metrics Best Publications

Daniel F. Hayes

University of Michigan–Ann Arbor
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 132 Citations 101,129 607 World Ranking 1268 National Ranking 749

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What are the main themes of his work throughout his whole career to date

Daniel F. Hayes merges Pathology with Immunohistochemistry in his study. He integrates Immunohistochemistry with Biopsy in his research. His research on Biopsy frequently connects to adjacent areas such as Internal medicine. He undertakes multidisciplinary studies into Internal medicine and Radiology in his work. Daniel F. Hayes connects Radiology with Pathology in his research. Many of his studies on Core biopsy involve topics that are commonly interrelated, such as Cancer. Cancer and Breast cancer are two areas of study in which Daniel F. Hayes engages in interdisciplinary work. His study ties his expertise on Core biopsy together with the subject of Breast cancer.

Daniel F. Hayes most often published in these fields:

Dermatology (50.00%)
Pathology (50.00%)
Core biopsy (50.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

American society of clinical oncology/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

Antonio C. Wolff;M. Elizabeth H. Hammond;Jared N. Schwartz;Karen L. Hagerty.
Journal of Clinical Oncology (2006)

5540 Citations

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond;Daniel F Hayes;Mitch Dowsett;D Craig Allred.
Journal of Clinical Oncology (2010)

5144 Citations

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Antonio C. Wolff;M. Elizabeth H. Hammond;Jared N. Schwartz;Karen L. Hagerty.
Archives of Pathology & Laboratory Medicine (2007)

4890 Citations

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Massimo Cristofanilli;G. Thomas Budd;Matthew J. Ellis;Alison Stopeck.
The New England Journal of Medicine (2004)

4874 Citations

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Christophe Ginestier;Min Hee Hur;Emmanuelle Charafe-Jauffret;Florence Monville.
Cell Stem Cell (2007)

4473 Citations

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

A Goldhirsch;E P Winer;A S Coates;R D Gelber.
Annals of Oncology (2013)

3457 Citations

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Lyndsay Harris;Herbert Fritsche;Robert Mennel;Larry Norton.
Journal of Clinical Oncology (2007)

2762 Citations

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Antonio C. Wolff;M. Elizabeth H Hammond;David G. Hicks;Mitch Dowsett.
Archives of Pathology & Laboratory Medicine (2014)

1911 Citations

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Celina G. Kleer;Qi Cao;Sooryanarayana Varambally;Ronglai Shen.
Proceedings of the National Academy of Sciences of the United States of America (2003)

1843 Citations

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

Mitch Dowsett;Torsten O. Nielsen;Roger A’Hern;John Bartlett.
Journal of the National Cancer Institute (2011)

1796 Citations

If you think any of the details on this page are incorrect, let us know.